bestliner.blogg.se - Icalamus 2 manual

230000004936 stimulating Effects 0.000 claims description 8.230000001506 immunosuppresive Effects 0.000 claims description 8.229920000160 (ribonucleotides)n+m Polymers 0.000 claims description 9.238000006467 substitution reaction Methods 0.000 claims description 10.102000004965 antibodies Human genes 0.000 claims description 14.206010006187 Breast cancer Diseases 0.000 claims description 14.

206010025650 Malignant melanoma Diseases 0.000 claims description 17.

102000004452 Arginases Human genes 0.000 claims description 22.

125000003275 alpha amino acid group Chemical group 0.000 claims description 23.

230000000875 corresponding Effects 0.000 claims description 26.

150000001413 amino acids Chemical class 0.000 claims description 28.

229920000023 polynucleotide Polymers 0.000 claims abstract description 29.

239000002157 polynucleotide Substances 0.000 claims abstract description 29.

239000000203 mixture Substances 0.000 claims abstract description 50.

102100008915 ARG1 Human genes 0.000 title claims abstract description 83.

101710038084 ARG1 Proteins 0.000 title claims abstract description 92.

229920001184 polypeptide Polymers 0.000 title claims abstract description 96.

Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to GBGB1815549.9A priority Critical patent/GB201815549D0/en Priority to GB1815549.9 priority Application filed by IO Biotech ApS filed Critical IO Biotech ApS Priority to PCT/EP2019/075731 priority patent/WO2020064744A1/en Publication of CN112771159A publication Critical patent/CN112771159A/en Status Pending legal-status Critical Current Links

Original Assignee IO Biotech ApS Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) 安德森 Current Assignee (The listed assignees may be inaccurate.Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Pending Application number CN201980062504.7A Other languages Chinese ( zh)